Morehouse School of Medicine and Freenome Present Research Demonstrating High Enrollment Rates for African Americans in Clinical Trial

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Oct. 27, 2021 /PRNewswire/ -- Freenome, a privately held biotech company, together with researchers from Morehouse School of Medicine, presented research earlier this week at the American College of Gastroenterology (ACG) annual meeting that demonstrates rates of enrollment in a colorectal cancer...

Click to view original post